NCT05797064

Brief Summary

The goal of this observational study is to test in patients with resectable rectosigmoid cancers. The main question it aims to answer is establishment of a feasibility model for predicting natural orifice specimen extraction surgery (NOSES) based on machine learning.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
460

participants targeted

Target at P75+ for all trials

Timeline
1mo left

Started Jun 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress98%
Jun 2023Jun 2026

First Submitted

Initial submission to the registry

March 21, 2023

Completed
14 days until next milestone

First Posted

Study publicly available on registry

April 4, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

June 1, 2023

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Last Updated

April 4, 2023

Status Verified

April 1, 2023

Enrollment Period

3 years

First QC Date

March 21, 2023

Last Update Submit

April 3, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • The number of successful operations performed

    Accuracy will be calculated by the number of successful operations performed

    3 years

  • The number of successful operations actually completed.

    Accuracy will be calculated by the number of successful operations actually completed.

    3 years

Study Arms (2)

Training set

The training set is a dataset used to train the model, which includes randomly enrolled patients with colon and rectal cancer. The inputs include data such as gender, age, height, weight, BMI, tumor stage, tumor pathology type, and the output information is whether NOSES surgery was successful or not. During training, the model learns from this dataset to make predictions on whether new patients with colon and rectal cancer can undergo NOSES surgery successfully.

Procedure: Natural Orifice Specimen Extraction Surgery

test set

The test set is a dataset used to evaluate the performance of a trained machine learning model. It includes another randomly enrolled group of patients with colon and rectal cancer, as well as their clinical and pathological data and surgical outcomes. The outputs are not used during training, but are used to test the trained model to evaluate its predictive ability on unknown data. The purpose is to evaluate the model's generalization ability, that is, its performance on new and unknown data.

Procedure: Natural Orifice Specimen Extraction Surgery

Interventions

Natural Orifice Specimen Extraction Surgery (NOSES) is a minimally invasive surgical technique that aims to reduce the size and number of incisions required during certain surgeries. In NOSES, the surgical specimen (such as a diseased organ or tumor) is removed from the body through a natural orifice (such as the mouth, anus, or vagina), rather than through an incision in the abdominal wall. In this trial, we will extract surgical specimens from the rectum to reduce trauma to the abdominal wall.

Also known as: NOSES
Training settest set

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients diagnosed with resectable rectosigmoid cancer.

You may qualify if:

  • Patients diagnosed with colorectal cancer or large adenoma who are suitable for laparoscopic colorectal surgery;
  • Tumor staging ≤ T3 without invasion of surrounding organs;
  • No abdominal seeding or distant organ metastasis;
  • Clear and complete imaging data (CT, pelvic MRI) that can be processed by a computer;
  • Feasible evaluation and determination for obtaining specimens through the rectal channel during preoperative and intraoperative assessments.

You may not qualify if:

  • Contraindications for laparoscopic colorectal surgery;
  • Tumor staging is T4, or there are cancer nodules;
  • Presence of metastasis or distant organ metastasis;
  • Incomplete imaging data;
  • Preoperative intestinal obstruction;
  • Tumor or specimen diameter larger than the transverse diameter of the pelvic outlet;
  • Previous rectal radiotherapy;
  • Unsuitable evaluation and determination for obtaining specimens through the rectal channel during preoperative and intraoperative assessments.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Sixth Affiliate Hospital of Sun Yat-Sen University

Guangzhou, Guangdong, China

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 21, 2023

First Posted

April 4, 2023

Study Start

June 1, 2023

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

June 1, 2026

Last Updated

April 4, 2023

Record last verified: 2023-04

Locations